Implantable cardioverter-defibrillator therapy before death: high risk for painful shocks at end of life

Alternate title: 
J2 - Circulation
Secondary title: 
T2 - Circulation
Short title: 
Implantable cardioverter-defibrillator therapy before death: high risk for painful shocks at end of life
Authors: 
Kinch Westerdahl, Annika
Sjoblom, Johanna
Mattiasson, Anne-Cathrine
Rosenqvist, Marten
Frykman, Viveka
Volume: 
129
Start page: 
422-9
Annotations: 
Type D, Priority 2
Date: 
Jan 28
Year: 
2014
Accession number: 
24243857
Database: 
MEDLINE Cohort
Number: 
M1 - 4
Serial: 
1524-4539
Type of work: 
M3 - Research Support, Non-U.S. Gov't
ID: 
12833
DOI: 
http://dx.doi.org/10.1161/CIRCULATIONAHA.113.002648
Notes: 
N1 - Kinch Westerdahl A Sjoblom J Mattiasson AC Rosenqvist M Frykman V Comment in: Nat Rev Cardiol. 2014 Feb;11(2):65; PMID: 24322547 Comment in: Circulation. 2014 Jan 28;129(4):414-6; PMID: 24243856
Key words: 
Aged
Aged, 80 and over
Arrhythmias, Cardiac/th [Therapy]
*Defibrillators, Implantable/ae [Adverse Effects]
*Electric Countershock/ae [Adverse Effects]
Equipment Failure
Female
Humans
Incidence
Male
Middle Aged
Prospective Studies
Retrospective Studies
Risk Factors
*Tachycardia, Ventricular/ep [Epidemiology]
*Tachycardia, Ventricular/mo [Mortality]
*Ventricular Fibrillation/ep [Epidemiology]
*Ventricular Fibrillation/mo [Mortality]
Types of evidence: 
Type D
Priorities of Care: 
Priority 2: Communicate